Clinical Trial

Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer

Name: Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer — clinical trial record (NCT07041437)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Our study is aimed to evaluate the efficacy and safety of SHR-A2102 combined other antitumor treatments in advanced breast cancer.

Trial Details

NCT Number	NCT07041437
Lead Sponsor	Fudan University
Conditions	Advanced Breast Cancer
Enrollment	48 participants
Start Date	2025-06-30
Primary Completion	2026-09-30 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-06-27